Roche has extended the expiration of its tender offer to purchase up to 15,604,288 of the outstanding common shares of Foundation Medicine, Inc. (FMI), at a price of $50.00 per share in cash, to 12:00 midnight, New York City time, at the end of the day on Monday, April 6, 2015. All other terms and conditions of the tender offer remain unchanged.

As of March 1, 2015, approximately 7,739,202 common shares of FMI (none of which were tendered by notice of guaranteed delivery) had been tendered and not withdrawn pursuant to the tender offer.

Subject to satisfaction or waiver of the remaining conditions to the tender offer (including receipt at thespecial meeting, currently scheduled for April 2, 2015, of the required approval of FMI’s stockholders), Roche does not currently anticipate a further extension to the tender offer.